OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

REGISTERED COMPANY NUMBER: 01700787 (England and Wales) REGISTERED CHARITY NUMBER: 802164

Trustees' Report and

Unaudited Financial Statements for the Year Ended 31 December 2025

for

The Society Of Musculoskeletal Medicine (A Company Limited by Guarantee)

The Society Of Musculoskeletal Medicine

Contents of the Financial Statements for the Year Ended 31 December 2025

Page
Reference and Administrative Details 1
Trustees' Report 2 to 5
Independent Examiner's Report 6
Statement of Financial Activities 7
Balance Sheet 8 to 9
Notes to the Financial Statements 10 to 15
Detailed Statement of Financial Activities 16

The Society Of Musculoskeletal Medicine

Reference and Administrative Details for the Year Ended 31 December 2025

TRUSTEES L Entwistle Chartered Accountant E L Atkins Physiotherapist G Cameron Medical Practitioner G Hebenton Chartered Physiotherapist J Neilson Health Care Manager D A Reid General Practitioner J P Smith Physiotherapist N Worth Physiotherapist REGISTERED OFFICE Somm 4th Floor 151 Dale Street Liverpool L2 2AH REGISTERED COMPANY 01700787 (England and Wales) NUMBER REGISTERED CHARITY 802164 NUMBER IINDEPENDENT EXAMINER Peter Wilson FCA Rockfield Business Centre 512 Darwen Road Bromley Cross Bolton BL7 BDX

Page 1

The Society Of Musculoskeletal Medicine

Trustees' Report for the Year Ended 31 December 2025

The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 December 2025. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).

OBJECTIVES AND ACTIVITIES

Objectives and activities

The Society of Musculoskeletal Medicine (SOMM) - formerly the Society of Orthopaedic Medicine - is an educational charitable company that was formed in 1979 to develop the seminal work of Dr James Cyriax MRCP and to promote the theory and the practice of musculoskeletal medicine.

SOMM provides a comprehensive programme of post graduate courses for physiotherapists and doctors that run primarily throughout the UK but invitations further afield are always considered and courses in Europe and South East Asia have been delivered in the past.

The Society has a committed team of tutors who have many years of experience practicing musculoskeletal medicine in many different arenas - NHS, sport, private practice and the armed forces. This brings diversity and interest in the courses and ensures a stimulating and varied learning experience.

The main objective of the Society during the past 12 months has been to sustain our ability to provide high quality musculoskeletal medicine training to result in better medical treatment for patients.

Our strategy has continued to focus on the need to strengthen our existing offering to current markets, in particular our international courses and our injection therapy courses

Public Benefit

The objects for which The Society of Musculoskeletal Medicine has been established are:

To benefit the public through the promotion and advancement of musculoskeletal medicine.

We will provide education to facilitate the practice, study and publication of research within this field.

The trustees have paid due regard to the Charity Commission guidance on public benefit in deciding SOMM activities to be undertaken and have only pursued activities with a public benefit outlined below.

The core activity of the Society is the teaching of musculoskeletal medicine through Foundation course modules, which aim to provide students with a practical approach to the clinical diagnosis and treatment of musculoskeletal conditions.

The outcome is a public benefit through being diagnosed or treated by medical practitioners or allied health professionals that are trained in SOMM principles and subsequently have confidence to practise this important area of medicine.

There is public benefit gained through sharing knowledge in this way so that patients receive the best possible diagnosis and treatment from fully informed doctors and allied health professionals.

ACHIEVEMENTS AND PERFORMANCE

Charitable activities

During 2025, SOMM continued to strengthen its educational delivery and tutor support structures. A Chair of Education was formally appointed, reinforcing our commitment to high quality teaching, improved academic governance, and enhanced support for our tutor team. This appointment also helped us stabilise teaching capacity following the loss of several experienced tutors.

Across the financial year, the Society delivered 11 Foundation Courses, training 175 students. A further 67 students completed the Theory and Practice of Injection Therapy module, while 45 students attended the Injection Therapy CPD Update Day.

In total, 297 students received SOMM training during 2025.

Page 2

The Society Of Musculoskeletal Medicine

Trustees' Report for the Year Ended 31 December 2025

FINANCIAL REVIEW Financial review

Total income for the period was £228,114 (2024: £281,704).

Total expenditure for the period was £254,197 (2024:£274,289).

The net loss for the year prior to gains and losses on investments was £26,083 (2024: gain £7,415). Gains on our investments of £23,741 during the year (see note 9) meant that our final position was a loss for the year of £2,342 (2024 gain for the year of £19,440 following gains on investments of £12,025).

At the end of 2025 the fixed asset investments were valued at £213,531 (2024: £228,790) this is after a cash withdrawal from the investment fund of £39,000 in October 2025 (see note 9).

The Society has a current bank account which at the year-end totalled £29,251 (2024: £37,088).

Investment policy

£213,531 is held in a broad range of investment funds, with an overarching conservative objective in order to minimise risk and safeguard the funds.

Quilter Cheviot is the appointed investment advisor, and they manage SOMM funds on a discretionary basis. This enables an improved speed of decision-making as the appointed investment managers are authorised to move funds according to market conditions.

The Council has requested that portfolio of investments be managed cautiously, within agreed parameters.

The Society Manager and Treasurer receive regular investment performance reports from Cheviot Asset Management, and can access real time valuations at any given juncture

Reserves policy

It is the policy of the charity that unrestricted funds which have not been designated for a specific use should be maintained at a level equivalent to between three and six month's expenditure. The trustees consider that reserves at this level will ensure that, in the event of a significant drop in funding, they will be able to continue the charity's current activities while consideration is given to ways in which additional funds may be raised. This level of reserves has been maintained throughout the year.

Risk Policy

The Council undertakes an annual review of the key risks facing the organisation. The main risks identified include:

Measures implemented during the year to mitigate these risks include:

All risks continue to be reviewed annually to ensure appropriate mitigation and oversight.

Page 3

The Society Of Musculoskeletal Medicine

for the Year Ended 31 December 2025

Trustees' Report

STRUCTURE, GOVERNANCE AND MANAGEMENT Structure, governance and management

The organisation is a charitable company; limited by guarantee (registered in England and Wales No.01700787) originally formed in 1979 and was incorporated on 11th January 1983. The company was established under a Memorandum of Association, which established the objects and powers of the company and is governed by its Articles of Association.

The charitable company was registered with the Charities Commission (registered number 802164) on 17th January 1990 as a charity for the benefit of the public in relieving sickness by promoting and advancing the use, study and science of orthopaedic medicine and by providing facilities for treatment, education, study and research therein.

The charitable company changed its name from The Society of Orthopaedic Medicine on 21 January 2013.

The trustees, who are also the directors for the purpose of company law, and who served during the year and up to the date of signature of the financial statements were:

Dr E L Atkins MBE Dr D A Reid Dr G Cameron Mr G Hebenton Mr N Worth Mr L Entwistle Mr J P Smith Mrs J Neilson

Members of the Council are elected/re-elected at the Annual General Meeting by the membership.

According to SOMM's constitution, 1/3 of elected Councillors will retire by rotation at each Annual General Meeting, with those that have been longest in office being first to retire. Officers of the Society are exempt from retiring for re-election partway through their term of office.

Some of the trustees are remunerated by the Society of Musculoskeletal Medicine (SOMM) for their professional services in teaching musculoskeletal medicine on behalf of SOMM. The Society governance includes strict policies and procedures that are in place to safeguard the organisation against any potential conflict of interest that might arise through such remuneration.

No Council members are remunerated for their trusteeship services.

Trustee Recruitment and Appointment

SOMM's constitution requires that Councillors be elected to office by the membership.

A call for nominations is sent to all SOMM members in advance of the Annual General Meeting.

Additionally, SOMM Council has the power to co-opt individuals.

All co-options are valid for 1 year until the date of the next Annual General Meeting, at which point Council may decide to renew the co-option.

Page 4

The Society Of Musculoskeletal Medicine

Trustees' Report for the Year Ended 31 December 2025

STRUCTURE, GOVERNANCE AND MANAGEMENT Trustee Induction and Training

All newly-elected trustees are sent an induction pack which includes the following items:

SOMM trustees are the main decision-makers for the organisation, and the trustee board is known as Council.

Trustees are updated on SOMM activities and performance through regular email communications from the Society Manager, at Council meetings, strategic planning meetings, and any other ad hoc meetings.

Sub-committees include the Education Committee.

All Committees have specific Terms of Reference which outline their responsibilities and reporting structure. All sub-committees report to SOMM Council.

Council has agreed a target that all incoming trustees should attend formal trustee training, and has also proactively encouraged current trustees to attend such training. To date, 50% of current trustees either have already received formal training or are planning to attend a training course in the coming year.

The Society Manager manages the performance and administration of the organisation, and attends all Council and Committee meetings.

Annual budgets are prepared by the Society Manager in collaboration with the office lead for finances and the Treasurer for approval by Council.

Council receives regular management accounts reports throughout the year.

Council has delegated authority for financial decisions up to the value of £10,000 to the Treasurer, and Society Manager, providing there is unanimity across the group. This policy is beneficial operationally because it enables timely decisions to be made and implemented.

Many action points have arisen including increasing financial, business and marketing skills on the Council, clarifying the relative roles of Society Manager and Council, increasing strategic activity, improving communications and decision-making.

Small company provisions

This report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.

Approved by order of the board of trustees on 24 March 2026 and signed on its behalf by:

L Entwistle - Trustee

Page 5

Independent Examiner's Report to the Trustees of The Society Of Musculoskeletal Medicine

I report to the trustees on my examination of the financial statements of The Society Of Musculoskeletal Medicine (the charity) for the year ended 31 December 2025.

This report is made solely to the charity's trustees, as a body, in accordance with section 145 of the Charities Act 2011. My work has been undertaken so that I might state to the charity's trustees those matters I am required to state to them in this report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the charity and the charity's trustees as a body, for my work, for this report, or for the opinions I have formed.

Responsibilities and basis of report

As the trustees of the charity (and also its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006 (the 2006 Act).

Having satisfied myself that the financial statements of the charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the charity's financial statements carried out under section 145 of the Charities Act 2011 (the 2011 Act). In carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent examiner's statement

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

1 accounting records were not kept in respect of the charity as required by section 386 of the 2006 Act; or 2 the financial statements do not accord with those records; or

3 the financial statements do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or

4 the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.

Peter Wilson FCA

24 March 2026

Page 6

The Society Of Musculoskeletal Medicine

Statement of Financial Activities for the Year Ended 31 December 2025

31.12.25 31.12.24
Unrestricted Total
fund funds
Notes £ £
INCOME FROM: FROM
Charitable activities
Charitable 221,217 274,748
Investment income 2 6,897 6,956
Total 228,114 281,704
EXPENDITURE ON
Raising funds 3 1,886 26
Charitable activities
Charitable 252,311 274,263
Total 254,197 274,289
Net gains on investments 23,741 12,025
NET INCOME/(EXPENDITURE) (2,342) 19,440
RECONCILIATION OF FUNDS
Total funds brought forward 159,655 140,215
TOTAL FUNDS CARRIED FORWARD 157,313 159,655

The notes form part of these financial statements

Page 7

The Society Of Musculoskeletal Medicine

Balance Sheet 31 December 2025

31.12.25
Unrestricted
fund
Notes
£
FIXED ASSETS
Tangible assets
8
4,567
Investments
9
213,531
218,098
CURRENT ASSETS
Stocks
10
3,994
Debtors
11
16,968
Cash in hand
29,251
50,213
CREDITORS
Amounts falling due within one year
12
(110,998)
NET CURRENT ASSETS
(60,785)
TOTAL ASSETS LESS CURRENT
LIABILITIES
157,313
NET ASSETS
157,313
FUNDS
13
Unrestricted funds
157,313
TOTAL FUNDS
157,313
31.12.24
Total
funds
£
3,465
228,790
232,255
5,144
24,509
37,088
66,741
(139,341)
(72,600)
159,655
159,655
159,655
159,655

The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The trustees acknowledge their responsibilities for

The notes form part of these financial statements

continued...

Page 8

The Society Of Musculoskeletal Medicine

Balance Sheet - continued 31 December 2025

These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.

The financial statements were approved by the Board of Trustees and authorised for issue on 24 March 2026 and were signed on its behalf by:

L Entwistle - Trustee

The notes form part of these financial statements

Page 9

The Society Of Musculoskeletal Medicine

Notes to the Financial Statements for the Year Ended 31 December 2025

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention, with the exception of investments which are included at market value.

Financial reporting standard 102 - reduced disclosure exemptions

The charitable company has taken advantage of the following disclosure exemption in preparing these financial statements, as permitted by FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland':

Income

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery - 25% on reducing balance Fixtures and fittings - 25% on reducing balance Computer equipment - 25% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

The charity is exempt from corporation tax on its charitable activities.

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

continued...

Page 10

The Society Of Musculoskeletal Medicine

Notes to the Financial Statements - continued for the Year Ended 31 December 2025

2. INVESTMENT INCOME
31.12.25 31.12.24
£ £
Income from listed investments 6,522 6,627
Interest receivable 375 329
6,897 6,956
3. RAISING FUNDS
Investment management costs
31.12.25 31.12.24
£ £
Investment management 1,886 26
4. NET INCOME/(EXPENDITURE)
Net income/(expenditure) is stated after charging/(crediting):
31.12.25 31.12.24
£ £
Depreciation - owned assets 1,523 1,156
5. TRUSTEES' REMUNERATION AND BENEFITS
There were no trustees' remuneration or other benefits for the year ended 31 December 2025 nor for the year
ended 31 December 2024.
6. STAFF COSTS
The average monthly number of employees during the year was as follows:
31.12.25 31.12.24
Charitable Activities 4 4
No employees received emoluments in excess of £60,000.
7. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted
fund
£
INCOME FROM: FROM
Charitable activities
Charitable 274,748
Investment income 6,956
Total 281,704
EXPENDITURE ON
Raising funds 26
Charitable activities
Charitable 274,263
Page 11 continued...

The Society Of Musculoskeletal Medicine

Notes to the Financial Statements - continued for the Year Ended 31 December 2025

7. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued

Unrestricted
fund
£
Total 274,289
Net gains on investments 12,025
NET INCOME 19,440
RECONCILIATION OF FUNDS
Total funds brought forward 140,215
TOTAL FUNDS CARRIED FORWARD 159,655
TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£ £ £ £
COST
At 1 January 2025 5,646 8,604 9,289 23,539
Additions - - 2,625 2,625
At 31 December 2025 5,646 8,604 11,914 26,164
DEPRECIATION
At 1 January 2025 5,612 8,228 6,234 20,074
Charge for year 9 94 1,420 1,523
At 31 December 2025 5,621 8,322 7,654 21,597
NET BOOK VALUE
At 31 December 2025 25 282 4,260 4,567
At 31 December 2024 34 376 3,055 3,465

8. TANGIBLE FIXED ASSETS

continued...

Page 12

The Society Of Musculoskeletal Medicine

Notes to the Financial Statements - continued for the Year Ended 31 December 2025

9. FIXED ASSET INVESTMENTS

MARKET VALUE
At 1 January 2025
Valuation changes
Movement capital & cash a/cs
At 31 December 2025
NET BOOK VALUE
At 31 December 2025
At 31 December 2024
There were no investment assets outside the UK.
10.
STOCKS
Finished goods & for resale
11.
DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Trade debtors
Prepayments and accrued income
12.
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Trade creditors
Other tax and social security
Other creditors
Deferred income
Accrued expenses
Listed
investments
£
228,790
23,741
(39,000)
213,531
213,531
228,790
31.12.25
31.12.24
£
£
3,994
5,144
31.12.25
31.12.24
£
£
16,650
19,475
318
5,034
16,968
24,509
31.12.25
31.12.24
£
£
11,427
39,232
3,778
4,127
30,993
30,852
63,660
64,050
1,140
1,080
110,998
139,341

continued...

Page 13

The Society Of Musculoskeletal Medicine

Notes to the Financial Statements - continued for the Year Ended 31 December 2025

13. MOVEMENT IN FUNDS

Unrestricted funds
General fund
TOTAL FUNDS
Net movement in funds, included in the above are as
Unrestricted funds
General fund
TOTAL FUNDS
follows:
Incoming
resources
£
228,114
228,114
At 1.1.25
£
159,655
159,655
Resources
expended
£
(254,197)
(254,197)
Net
movement
At
in funds
31.12.25
£
£
(2,342)
157,313
(2,342)
157,313
Gains and
Movement
losses
in funds
£
£
23,741
(2,342)
23,741
(2,342)

Comparatives for movement in funds

At 1.1.24
£
Unrestricted funds
General fund
140,215
TOTAL FUNDS
140,215
Comparative net movement in funds, included in the above are as follows:
Incoming
Resources
resources
expended
£
£
Unrestricted funds
General fund
281,704
(274,289)
TOTAL FUNDS
281,704
(274,289)
Net
movement
At
in funds
31.12.24
£
£
19,440
159,655
19,440
159,655
Gains and
Movement
losses
in funds
£
£
12,025
19,440
12,025
19,440

continued...

Page 14

The Society Of Musculoskeletal Medicine

Notes to the Financial Statements - continued for the Year Ended 31 December 2025

13. MOVEMENT IN FUNDS - continued

A current year 12 months and prior year 12 months combined position is as follows:

Unrestricted funds
General fund
TOTAL FUNDS
At 1.1.24
£
140,215
140,215
Net
movement
in funds
£
17,098
17,098
At
31.12.25
£
157,313
157,313

A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
TOTAL FUNDS
Incoming
resources
£
509,818
509,818
Resources
expended
£
(528,486)
(528,486)
Gains and
Movement
losses
in funds
£
£
35,766
17,098
35,766
17,098
Gains and
Movement
losses
in funds
£
£
35,766
17,098
35,766
17,098
17,098

14. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 31 December 2025.

Page 15

The Society Of Musculoskeletal Medicine
Detailed Statement of Financial Activities
for the Year Ended 31 December 2025
31.12.25 31.12.24
£ £
INCOME FROM:
Investment income
Income from listed investments 6,522 6,627
Interest receivable 375 329
6,897 6,956
Charitable activities
Charitable activities 221,217 273,818
Other income - 930
221,217 274,748
Total incoming resources 228,114 281,704
EXPENDITURE
Investment management costs
Investment management 1,886 26
Charitable activities
Wages 85,938 85,858
Rent and rates 7,583 8,595
Insurance 548 517
Telephone and internet 1,018 1,211
Printing, postage & stationery 2,367 1,641
Promotion and advertising 2,585 3,223
General expenses 898 9,783
Computer and website costs 2,538 2,207
Subscriptions 5,098 3,311
Repairs and renewals 590 557
Meeting costs 7,757 14,224
Bank charges 2,837 3,930
Legal and professional fees 1,715 4,847
Accountancy 1,140 2,240
Courses and examination costs 128,176 130,963
Depreciation of tangible fixed assets 1,523 1,156
252,311 274,263
Total resources expended 254,197 274,289
Net (expenditure)/income before gains and
losses (26,083) 7,415
Realised recognised gains and losses
Revaluation of investments 23,741 12,025
Net (expenditure)/income (2,342) 19,440

This page does not form part of the statutory financial statements

Page 16